{"id":30311,"date":"2025-10-01T07:05:21","date_gmt":"2025-10-01T07:05:21","guid":{"rendered":"https:\/\/www.euegeajans.com\/?p=30311"},"modified":"2025-10-01T07:05:23","modified_gmt":"2025-10-01T07:05:23","slug":"egeli-akademisyenden-akciger-kanserine-karsi-yenilikci-tedavi-yaklasimi","status":"publish","type":"post","link":"https:\/\/www.euegeajans.com\/index.php\/2025\/10\/01\/egeli-akademisyenden-akciger-kanserine-karsi-yenilikci-tedavi-yaklasimi\/","title":{"rendered":"Egeli akademisyenden akci\u011fer kanserine kar\u015f\u0131 yenilik\u00e7i tedavi yakla\u015f\u0131m\u0131"},"content":{"rendered":"<p style=\"font-weight: 400; text-align: justify;\">Ege \u00dcniversitesi Eczac\u0131l\u0131k Fak\u00fcltesi Farmas\u00f6tik Biyoteknoloji Anabilim Dal\u0131 \u00f6\u011fretim \u00fcyesi Do\u00e7. Dr. Hasan Akbaba\u2019n\u0131n y\u00fcr\u00fct\u00fcc\u00fcl\u00fc\u011f\u00fcn\u00fc \u00fcstlendi\u011fi \u201cAkci\u011fer kanserinin tedavisine y\u00f6nelik terap\u00f6tik gen d\u00fczenlemesi amac\u0131yla ribon\u00fckleoprotein y\u00fckl\u00fc lipit nanopartik\u00fcllerin piezoelektrik inhalasyon sistemleri ile iletimi\u201d ba\u015fl\u0131kl\u0131 proje, T\u00dcB\u0130TAK 2515 \u2013COST Aksiyon \u00dcyeleri Ar-Ge Destek Program\u0131 kapsam\u0131nda desteklenmeye uygun bulundu. Proje kapsam\u0131nda \u00e7a\u011f\u0131n hastal\u0131\u011f\u0131 olan kanserin tedavisine y\u00f6nelik olarak yenilik\u00e7i ve multidisipliner bir yakla\u015f\u0131mla gen tedavisi ger\u00e7ekle\u015ftirilecek.<\/p>\n<p style=\"font-weight: 400; text-align: justify;\">Proje ekibini makam\u0131nda a\u011f\u0131rlayarak tebrik eden Ege \u00dcniversitesi Rekt\u00f6r\u00fc Prof. Dr. Necdet Budak, \u201c\u00dcniversitemizde olu\u015fturdu\u011fumuz s\u00fcrd\u00fcr\u00fclebilir bilim iklimi \u00e7er\u00e7evesinde \u00fcretken akademisyenlerimiz taraf\u0131ndan haz\u0131rlanan projeler, T\u00dcB\u0130TAK ve T\u00dcSEB nezdinde desteklenmeye devam ediyor. Eczac\u0131l\u0131k Fak\u00fcltesi \u00f6\u011fretim \u00fcyemiz Do\u00e7. Dr. Hasan Akbaba ve ekibinin ger\u00e7ekle\u015ftirdi\u011fi proje ile kanser tedavisine y\u00f6nelik gen tedavileri geli\u015ftirilecek. Sa\u011fl\u0131k temal\u0131 bir \u00fcniversite olarak bu alanda \u00f6nemli projeler \u00fcretmeye devam ediyoruz. Hocam\u0131z\u0131 ve ekibini \u00e7al\u0131\u015fmalar\u0131ndan \u00f6t\u00fcr\u00fc tebrik ediyorum\u201d dedi. Ziyaret esnas\u0131nda Do\u00e7. Dr. Akbaba, Prof. Dr. Budak\u2019a, proje d\u0131\u015f\u0131nda, yurt d\u0131\u015f\u0131nda ger\u00e7ekle\u015ftirdikleri mRNA a\u015f\u0131lar\u0131n\u0131n uygulamas\u0131na y\u00f6nelik mikroi\u011fne sistemlerinin geli\u015ftirilmesi \u00e7al\u0131\u015fmalar\u0131 ve alan\u0131n\u0131n en prestijli dergilerinden olan \u201cNature Immunology\u201d dergisinde \u00e7\u0131kan makalesi ile ilgili bilgiler de aktard\u0131.<\/p>\n<p style=\"font-weight: 400; text-align: justify;\"><strong>\u201cCRISPR teknolojisi do\u011frudan kanserli h\u00fccre \u00e7ekirde\u011fine hedeflenecek\u201d<\/strong><\/p>\n<p style=\"font-weight: 400; text-align: justify;\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-30313 alignleft\" src=\"http:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-300x200.jpg 300w, https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-1024x683.jpg 1024w, https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-768x512.jpg 768w, https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak.jpg 1500w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>Proje kapsam\u0131nda akci\u011fer kanserinin tedavisine y\u00f6nelik olarak hedeflenebilir ve etkin gen tedavisi yakla\u015f\u0131m\u0131n\u0131n geli\u015ftirilece\u011fini ifade eden Do\u00e7. Dr. Hasan Akbaba, \u201cGen tedavisinin yayg\u0131nla\u015fmas\u0131, etkinli\u011finin ve g\u00fcvenilirli\u011finin artmas\u0131 i\u00e7in ke\u015ffedilen molek\u00fcler yolaklar ve mekanizmalar kadar bu yolaklarda etkin materyallerin ilgili b\u00f6lgelere ta\u015f\u0131nmas\u0131 da olduk\u00e7a \u00f6nemlidir. CRISPR-Cas9 sisteminin gen tedavisi amac\u0131yla kullan\u0131lmas\u0131n\u0131n g\u00fcndeme gelmesinden sonra bu sistemi etki yerine ula\u015ft\u0131racak ta\u015f\u0131y\u0131c\u0131 sistemler geli\u015ftirilmesi \u00f6nem kazanm\u0131\u015ft\u0131r.\u00a0 Projenin amac\u0131, molek\u00fcler bir teknik olan \u2018CRISPR\/Cas9\u2019 teknolojisinin terap\u00f6tik ama\u00e7la kullan\u0131m\u0131 i\u00e7in enzim ve sgRNA kompleksinin lipit nanopartik\u00fcller i\u00e7erisinde enkaps\u00fcle edilmesi ve y\u00fczey modifikasyonlar\u0131 ile bu nanopartik\u00fcllerin h\u00fccre ve \u00e7ekirdek (n\u00fckleus) penetrasyonlar\u0131n\u0131n art\u0131r\u0131lmas\u0131d\u0131r. Haz\u0131rlanan form\u00fclasyonlar ile \u00e7ok hedefli bir tedavi yakla\u015f\u0131m\u0131 ger\u00e7ekle\u015ftirilecek olup farkl\u0131 molek\u00fcler yolaklar akci\u011fer kanserine spesifik hedefleyici peptit kombinasyonu kullan\u0131larak uygulanacakt\u0131r. Uygulama yolu olarak inhalasyon yola\u011f\u0131 tercih edilmekle birlikte, haz\u0131rlanan LNP s\u00fcspansiyonu pizeoelektrik sistemler arac\u0131l\u0131\u011f\u0131 ile aerosol forma getirilerek uygulama ger\u00e7ekle\u015ftirilecektir\u201d dedi.<\/p>\n<p style=\"font-weight: 400; text-align: justify;\">Projenin geli\u015fim s\u00fcrecini anlatan Do\u00e7. Dr. Akbaba, \u201cBu proje, doktora \u00f6\u011frencim Uzm.\u00a0 Ecz. Deniz Onan\u2019\u0131n doktora tezi \u00e7al\u0131\u015fmalar\u0131 esnas\u0131nda geli\u015ftirdi\u011fimiz \u00e7al\u0131\u015fmalar\u0131n devam\u0131 ve geli\u015ftirilmi\u015f bir halidir. Ayr\u0131ca, Uzm.\u00a0 Ecz. Deniz Onan\u2019\u0131n doktora tezi kapsam\u0131ndaki \u00e7al\u0131\u015fmalar\u0131n\u0131 y\u00fcr\u00fct\u00fcc\u00fcl\u00fc\u011f\u00fcn\u00fc de \u00fcstlendi\u011fi T\u00dcSEB-A3-01 projesi d\u0131\u015f kaynakl\u0131 olarak desteklemesi olduk\u00e7a \u00f6nemli bir ba\u015far\u0131d\u0131r.\u201d dedi.<\/p>\n<p style=\"font-weight: 400; text-align: justify;\"><strong>Multidisipliner ara\u015ft\u0131rma ekibi<\/strong><\/p>\n<p style=\"font-weight: 400; text-align: justify;\">Do\u00e7. Dr. Hasan Akbaba\u2019n\u0131n y\u00fcr\u00fct\u00fcc\u00fc oldu\u011fu proje ekibinde; Ege \u00dcniversitesi Eczac\u0131l\u0131k Fak\u00fcltesi Farmas\u00f6tik Biyoteknoloji Anabilim Dal\u0131 doktora \u00f6\u011frencisi Deniz Onan,\u00a0 Ege \u00dcniversitesi A\u015f\u0131 Geli\u015ftirme Uygulama ve Ara\u015ft\u0131rma Merkezi Y\u00f6netim Kurulu Ba\u015fkan Yard\u0131mc\u0131s\u0131 Prof. Dr. Mert D\u00f6\u015fkaya dan\u0131\u015fmanl\u0131k g\u00f6revini \u00fcstlenirken, \u00a0Do\u00e7 Dr. H\u00fcseyin Can ve Do\u00e7. Dr. Muhammet Karakavuk ara\u015ft\u0131rmac\u0131 olarak yer al\u0131yor. Projenin kurum d\u0131\u015f\u0131 payda\u015flar\u0131nda; \u0130zmir K\u00e2tip \u00c7elebi \u00dcniversitesi Eczac\u0131l\u0131k Fak\u00fcltesi Farmas\u00f6tik Biyoteknoloji Anabilim Dal\u0131 \u00f6\u011fretim \u00fcyesi Do\u00e7. Dr. G\u00fcl\u015fah Erel Akbaba ve \u0130zmir Biyot\u0131p ve Genom Merkezinden Do\u00e7. Dr. \u015eerif \u015eent\u00fcrk bulunuyor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ege \u00dcniversitesi Eczac\u0131l\u0131k Fak\u00fcltesi Farmas\u00f6tik Biyoteknoloji Anabilim Dal\u0131 \u00f6\u011fretim \u00fcyesi Do\u00e7. Dr. Hasan Akbaba\u2019n\u0131n y\u00fcr\u00fct\u00fcc\u00fcl\u00fc\u011f\u00fcn\u00fc&#8230;<\/p>\n","protected":false},"author":2,"featured_media":30312,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69,99,1,70],"tags":[],"class_list":["post-30311","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bilim","category-egitim","category-gncl","category-kampus"],"featured_image_urls":{"full":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-Uzm.-Ecz.-Deniz-Onan-2.jpg",1500,1000,false],"thumbnail":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-Uzm.-Ecz.-Deniz-Onan-2-150x150.jpg",150,150,true],"medium":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-Uzm.-Ecz.-Deniz-Onan-2-300x200.jpg",300,200,true],"medium_large":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-Uzm.-Ecz.-Deniz-Onan-2-768x512.jpg",640,427,true],"large":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-Uzm.-Ecz.-Deniz-Onan-2-1024x683.jpg",640,427,true],"1536x1536":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-Uzm.-Ecz.-Deniz-Onan-2.jpg",1500,1000,false],"2048x2048":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-Uzm.-Ecz.-Deniz-Onan-2.jpg",1500,1000,false],"newsphere-slider-full":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-Uzm.-Ecz.-Deniz-Onan-2-1280x720.jpg",1280,720,true],"newsphere-featured":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-Uzm.-Ecz.-Deniz-Onan-2-1024x683.jpg",1024,683,true],"newsphere-medium":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/10\/Doc.Dr_.Hasan-Akbaba-Prof.-Dr.-Necdet-Budak-Uzm.-Ecz.-Deniz-Onan-2-720x380.jpg",720,380,true]},"author_info":{"display_name":"Editor","author_link":"https:\/\/www.euegeajans.com\/index.php\/author\/editor\/"},"category_info":"<a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/bilim\/\" rel=\"category tag\">Bilim<\/a> <a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/egitim\/\" rel=\"category tag\">E\u011fitim<\/a> <a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/gncl\/\" rel=\"category tag\">G\u00fcncel<\/a> <a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/kampus\/\" rel=\"category tag\">Kamp\u00fcs<\/a>","tag_info":"Kamp\u00fcs","comment_count":"0","_links":{"self":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/30311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/comments?post=30311"}],"version-history":[{"count":1,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/30311\/revisions"}],"predecessor-version":[{"id":30314,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/30311\/revisions\/30314"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/media\/30312"}],"wp:attachment":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/media?parent=30311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/categories?post=30311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/tags?post=30311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}